logo-loader
viewFutura Medical PLC

Futura Medical on the rise as Liberum says newspaper article could spark interest in group’s main ED product

Over the weekend The Guardian published an in-depth piece on the emerging treatments for erectile dysfunction (ED) with a significant focus on Futura's MED2005 product

Couple in bed
“This will help to drive interest in what appears to be a very over-looked product in terms of its potential to address a very large market," Liberum's analysts said

Futura Medical PLC (LON:FUM) saw its shares shoot higher on Monday after ‘house’ broker Liberum Capital highlighted an article published in ‘The Guardian’ newspaper which could spark interest in the group’s main product.

In a note to clients, the City broker’s analysts pointed out that over the weekend the newspaper published an in-depth piece on the emerging treatments for erectile dysfunction (ED) with a significant focus on the AIM-listed firm’s MED2005 which is in a P3 study due to read-out by the end of the year.

READ: Futura Medical trial on track to deliver “major value inflection point”

They said: “The article highlights the lack of clinical advances in ED over the past 20 years and the emerging opportunity for products that can address the shortcomings of the PDe-5 inhibitor class (Viagra) with MED2005 appearing to offer convenience and side-effect profile benefits.”

The analysts concluded: “This will help to drive interest in what appears to be a very over-looked product in terms of its potential to address a very large market.”

In afternoon trading, shares in Futura Medical were up 11.6% at 23.15p.

Quick facts: Futura Medical PLC

Price: 34.03 GBX

AIM:FUM
Market: AIM
Market Cap: £69.65 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Futura Medical PLC named herein, including the promotion by the Company of Futura Medical PLC in any Content on the Site, the Company receives...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Investor Update: Block Energy completes critical phase of WR-38Z sidetrack

Headlines from Proactive UK newsroom. Block Energy (LON:BLOE) has completed a critical phase of the sidetrack programme at its WR-38Z well on the West Rustavi field in Georgia. New casing has been cemented through the build section of the well, which will prevent fluid incursion into the...

4 weeks ago

2 min read